IL154363A0 - Substituted amino-aza-cycloalkanes useful against malaria - Google Patents
Substituted amino-aza-cycloalkanes useful against malariaInfo
- Publication number
- IL154363A0 IL154363A0 IL15436301A IL15436301A IL154363A0 IL 154363 A0 IL154363 A0 IL 154363A0 IL 15436301 A IL15436301 A IL 15436301A IL 15436301 A IL15436301 A IL 15436301A IL 154363 A0 IL154363 A0 IL 154363A0
- Authority
- IL
- Israel
- Prior art keywords
- aza
- substituted amino
- useful against
- against malaria
- cycloalkanes
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP0009328 | 2000-09-25 | ||
| PCT/EP2001/010272 WO2002024649A1 (fr) | 2000-09-25 | 2001-09-06 | Amino-aza-cycloalcanes substitues utiles contre la malaria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL154363A0 true IL154363A0 (en) | 2003-09-17 |
Family
ID=8164106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15436301A IL154363A0 (en) | 2000-09-25 | 2001-09-06 | Substituted amino-aza-cycloalkanes useful against malaria |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040102431A1 (fr) |
| JP (1) | JP2004509866A (fr) |
| KR (1) | KR20030029978A (fr) |
| CN (1) | CN1458923A (fr) |
| AU (1) | AU2001291830A1 (fr) |
| BR (1) | BR0113989A (fr) |
| CA (1) | CA2423315A1 (fr) |
| HU (1) | HUP0303360A2 (fr) |
| IL (1) | IL154363A0 (fr) |
| MX (1) | MXPA03001982A (fr) |
| NO (1) | NO20031331D0 (fr) |
| WO (1) | WO2002024649A1 (fr) |
| ZA (1) | ZA200302290B (fr) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002304733A1 (en) * | 2001-04-17 | 2002-10-28 | Actelion Pharmaceuticals Ltd. | Amino-aza-cyclohexanes for the treatment of malaria |
| US7122675B2 (en) * | 2001-08-03 | 2006-10-17 | Schering Corporation | Gamma secretase inhibitors |
| AU2002367427A1 (en) * | 2001-12-28 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Biaryl compound and use thereof |
| TW200409637A (en) | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
| AU2003249983A1 (en) * | 2002-07-18 | 2004-02-09 | Actelion Pharmaceuticals Ltd | Piperidines useful for the treatment of central nervous system disorders |
| CA2511242C (fr) | 2002-12-20 | 2010-01-12 | Anita Melikian | Inhibiteurs de ccxckr2 d'expression tumorale humaine |
| MXPA05007568A (es) | 2003-01-16 | 2005-09-21 | Acadia Pharm Inc | Agonistas inversos del receptor selectivo de serotonina 2a/2c como terapeuticos para enfermedades neurodegenerativas. |
| CA2516642C (fr) * | 2003-02-21 | 2010-11-23 | Jarrow Formulas, Inc. | Procedes pour le traitement de vih ou de paludisme mettant en oeuvre des combinaisons de chloroquine et des inhibiteurs de protease |
| AP2005003467A0 (en) | 2003-06-17 | 2006-12-31 | Pfizer | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline reuptake inhibitors. |
| WO2005019176A1 (fr) * | 2003-08-25 | 2005-03-03 | Actelion Pharmaceuticals Ltd | Amino-aza-cyclohexanes substitues |
| WO2005058822A1 (fr) * | 2003-12-17 | 2005-06-30 | Actelion Pharmaceuticals Ltd | Cycloalcanes amines substitues |
| EP1735302B1 (fr) | 2004-02-27 | 2010-06-16 | Eli Lilly And Company | Derives de 4-amino-piperidine utilises en tant qu'inhibiteurs de l'absorption des monoamines |
| US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US7820695B2 (en) | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
| WO2006004880A2 (fr) | 2004-06-30 | 2006-01-12 | Schering Corporation | Amines heterocycliques a substitution n-arylsulfonyle inhibant la gamma secretase |
| US7417062B2 (en) * | 2004-09-29 | 2008-08-26 | Chemocentryx, Inc. | Substituted arylamides |
| TW200630337A (en) | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
| JP2008521793A (ja) * | 2004-11-25 | 2008-06-26 | アクテリオン ファーマシューティカルズ リミテッド | 新規４−アミノピペリジン誘導体 |
| WO2007110449A1 (fr) | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Composés de benzènesulfonamide et utilisation de ceux-ci |
| WO2007118854A1 (fr) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Composés à base de benzènesulfonamide et leur utilisation |
| US8791264B2 (en) * | 2006-04-13 | 2014-07-29 | Purdue Pharma L.P. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
| WO2008116024A2 (fr) | 2007-03-19 | 2008-09-25 | Acadia Pharmaceuticals Inc. | Combinaisons d'agonistes ou antagonistes inverses de 5-ht2a avec antipsychotiques |
| WO2008124118A1 (fr) | 2007-04-09 | 2008-10-16 | Purdue Pharma L.P. | Composés benzènesulfonylés et leur utilisation |
| US8765736B2 (en) * | 2007-09-28 | 2014-07-01 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| WO2009106599A2 (fr) * | 2008-02-29 | 2009-09-03 | Novartis Ag | Pipéridines substituées en tant que composés thérapeutiques |
| WO2011060271A1 (fr) * | 2009-11-12 | 2011-05-19 | The Trustees Of The University Of Pennsylvania | Criblage d'inhibiteurs de p. falciparum à l'aide d'un dosage de criblage haut rendement à base de luciférase |
| KR101035503B1 (ko) * | 2010-03-19 | 2011-05-20 | 변태희 | 맞춤형 어버트먼트 가공용 자재 |
| WO2012075241A2 (fr) | 2010-12-01 | 2012-06-07 | The Methodist Hospital System | Polypeptides dégradables par une protéase et leurs utilisations |
| US9439976B2 (en) | 2013-02-13 | 2016-09-13 | The Methodist Hospital System | Compositions and methods for using cathepsin E cleavable substrates |
| CA2901920A1 (fr) | 2013-03-15 | 2014-09-18 | Actelion Pharmaceuticals Ltd | Nouveaux derives d'acrylamide comme agents antipaludiques |
| US10464896B2 (en) | 2015-06-11 | 2019-11-05 | Basilea Pharmaceutica International AG | Efflux-pump inhibitors and therapeutic uses thereof |
| PT3325444T (pt) | 2015-07-20 | 2021-09-22 | Acadia Pharm Inc | Métodos para preparar n-(4-fluorobenzil)-n-(1-metilpiperidina-4-il)-n'-(4-(2-metilpropiloxi)fenilmetil)carbamida e o seu sal de tartarato e forma polimórfica c |
| DK3350165T3 (da) | 2015-09-16 | 2023-09-25 | Organovo Inc | Farnesoid-X-receptoragonister og anvendelser deraf |
| ES2922080T3 (es) | 2015-09-18 | 2022-09-07 | St Jude Childrens Res Hospital | Métodos y composiciones de inhibición de la interacción de DCN1-UBC12 |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| WO2017165635A1 (fr) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Association de pimavansérine et de modulateurs du cytochrome p450 |
| WO2018118626A1 (fr) | 2016-12-20 | 2018-06-28 | Acadia Pharmaceuticals Inc. | Pimavansérine seule ou en association pour une utilisation dans le traitement de la psychose liée à la maladie d'alzheimer |
| WO2018170166A1 (fr) | 2017-03-15 | 2018-09-20 | Metacrine, Inc. | Agonistes du récepteur farnésoïde x et leurs utilisations |
| MX2019010907A (es) | 2017-03-15 | 2019-11-07 | Metacrine Inc | Agonistas del receptor x farnesoide, y usos de los mismos. |
| EP3615028A1 (fr) | 2017-04-28 | 2020-03-04 | Acadia Pharmaceuticals Inc. | Pimavansérine pour le traitement d'un trouble de contrôle des impulsions |
| WO2019046167A1 (fr) | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | Formulations de pimavansérine |
| BR112021004919A2 (pt) | 2018-09-18 | 2021-06-01 | Metacrine, Inc. | agonistas de receptor farnesoide x e usos dos mesmos |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ2285A1 (fr) * | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Inhibiteurs de protéase de la cystéine. |
| AU9740998A (en) * | 1997-09-08 | 1999-03-29 | F. Hoffmann-La Roche Ag | Piperidine derivatives against malaria |
| KR20080059687A (ko) * | 2000-03-06 | 2008-06-30 | 아카디아 파마슈티칼스 인코포레이티드 | 세로토닌 관련 질병의 치료에 사용되는 아자시클릭 화합물 |
| CA2406652A1 (fr) * | 2000-04-20 | 2001-11-01 | Nps Allelix Corp. | Aminopiperidines |
-
2001
- 2001-09-06 MX MXPA03001982A patent/MXPA03001982A/es unknown
- 2001-09-06 KR KR10-2003-7003598A patent/KR20030029978A/ko not_active Application Discontinuation
- 2001-09-06 IL IL15436301A patent/IL154363A0/xx unknown
- 2001-09-06 WO PCT/EP2001/010272 patent/WO2002024649A1/fr not_active Application Discontinuation
- 2001-09-06 CA CA002423315A patent/CA2423315A1/fr not_active Abandoned
- 2001-09-06 CN CN01815832A patent/CN1458923A/zh active Pending
- 2001-09-06 US US10/381,567 patent/US20040102431A1/en not_active Abandoned
- 2001-09-06 AU AU2001291830A patent/AU2001291830A1/en not_active Abandoned
- 2001-09-06 JP JP2002529062A patent/JP2004509866A/ja active Pending
- 2001-09-06 HU HU0303360A patent/HUP0303360A2/hu unknown
- 2001-09-06 BR BR0113989-4A patent/BR0113989A/pt not_active Application Discontinuation
-
2003
- 2003-03-24 ZA ZA200302290A patent/ZA200302290B/en unknown
- 2003-03-24 NO NO20031331A patent/NO20031331D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03001982A (es) | 2004-05-14 |
| CA2423315A1 (fr) | 2002-03-28 |
| NO20031331L (no) | 2003-03-24 |
| CN1458923A (zh) | 2003-11-26 |
| WO2002024649A1 (fr) | 2002-03-28 |
| ZA200302290B (en) | 2004-06-30 |
| US20040102431A1 (en) | 2004-05-27 |
| JP2004509866A (ja) | 2004-04-02 |
| AU2001291830A1 (en) | 2002-04-02 |
| BR0113989A (pt) | 2004-01-27 |
| NO20031331D0 (no) | 2003-03-24 |
| HUP0303360A2 (hu) | 2004-01-28 |
| KR20030029978A (ko) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL154363A0 (en) | Substituted amino-aza-cycloalkanes useful against malaria | |
| DZ3293A1 (fr) | Arylpyrazines substitues | |
| AU3391801A (en) | Pyridinylimidazoles | |
| AU8274301A (en) | Electro-powder | |
| AU6227101A (en) | Substituted iminoazines | |
| AU6803901A (en) | Bis-arylsulfones | |
| DE50102859D1 (en) | Hochfliessfähige propylenblockcopolymerisate | |
| AU5825501A (en) | Substituted benzoylcyclohexenones | |
| AU9385201A (en) | Sulfonylguanidine | |
| PL358119A1 (en) | Substituted phenyluracils | |
| GB0017033D0 (en) | Inco-stop | |
| AU6619001A (en) | Liquid-pourers | |
| DE50008447D1 (en) | Aminomethyl-phenyl-cyclohexanonderivate | |
| AU4686401A (en) | Hypotensors | |
| AU9187601A (en) | Triazolo-epothilones | |
| DE50100877D1 (en) | Thermoverformbares verbundmaterial | |
| DE50006446D1 (en) | Otoplastik | |
| AU4831301A (en) | Gm-negative ehv-mutants | |
| AU8756801A (en) | Thienopyrrolidinones | |
| DE50003404D1 (en) | Multi-master-bus-system | |
| DE50013705D1 (en) | Otoplastik | |
| AU2360402A (en) | Substituted phenyluracils | |
| AU1702P (en) | Trailblazer Xanthostemon chrysanthus | |
| DE50103785D1 (en) | Common-rail-system | |
| AU2117P (en) | Gauka Gaura lindheimeri |